For patients with prostate cancer, theranostics may be another available treatment path to take, especially for those who need more options. For patients with prostate cancer, there are many ...

The FDA has granted premarket approval (PMA) to the IsoPSA test, a novel, blood-based in vitro diagnostic kit designed to ...

Early detection of prostate cancer could soon be simplified, thanks to a University of Otago – Ōtākou Whakaihu Waka project.

Quality of life, treatment impact and duration, and the importance of individualized therapy are at the center of international research on androgen deprivation therapy (ADT) for prostate cancer ...

Combined androgen blockade shows significant survival benefits over single-agent ADT in high-risk prostate cancer, as demonstrated by the PRESTO, EMBARK, and ENZARAD trials. The PRESTO trial ...

The Prostate Cancer Foundation (PCF) is proud to announce the launch of an interactive website and downloadable guide, Somatic and Germline Genetic Testing for Patients with Advanced Prostate ...

TULSA reduces tumor volume and PSA levels, improving urinary and sexual function in prostate cancer patients. Five-year TACT study data shows 80% of patients had no significant disease after one ...

The most common symptoms of prostate cancer are needing to urinate more often and straining to pee. Men may also feel as though their bladder has not fully emptied. These symptoms are common and do ...

James Pickens Jr. is emphasizing the importance of routine screenings after being diagnosed with prostate cancer.

The UK National Screening Committee said on Friday there were more harms than benefits to using the PSA test for screening all men.